Nu Skin Enterprises reported fourth quarter 2025 revenue of $370.3 million and diluted EPS of $0.29, both within guidance. The company achieved over 50% growth in earnings for the full year 2025, driven by effective margin improvement and cost optimization. Strategic initiatives like the global launch of Prysm iO and pre-market activities in India are expected to drive year-over-year revenue growth by the end of 2026.

Nu Skin Enterprises reported first quarter 2025 revenue of $364.5 million, which was at the high end of their guidance. The company's EPS was $2.14, or $0.23 excluding Mavely gain and other charges. They saw year-over-year growth in Latin America and their Rhyz manufacturing segment, but experienced consumer caution in premium beauty due to inflation and tariffs.

Nu Skin Enterprises exceeded its latest revenue guidance for both the fourth quarter and full-year 2024, driven by sequential revenue growth and the material completion of its restructuring plan. The company reported a fourth-quarter revenue of $445.6 million and an adjusted EPS of $0.38, while full-year revenue reached $1.73 billion with an adjusted EPS of $0.84.

Nu Skin Enterprises reported Q3 2024 revenue of $430.1 million, a decrease of 13.8% year-over-year, but within the guidance range. EPS was $0.17, compared to $(0.74) in the prior year, or $0.56 excluding an inventory write-off. The Rhyz segment continued to show strong growth, while the company focuses on strengthening the Nu Skin core business and improving profitability.

Nu Skin Enterprises reported second-quarter results in line with top-line guidance. Revenue was $439.1 million, a decrease of 12.2% year-over-year, but in line with expectations despite FX headwinds. Rhyz revenue grew by 32.3%. Reported EPS was $(2.38), but adjusted EPS excluding restructuring and impairment charges was $0.21.

Nu Skin Enterprises reported first quarter results in line with guidance. Revenue was $417.3 million, a decrease of 13.3% year-over-year, but Rhyz revenue increased by 57.5%. The company reported a loss per share of $(0.01), or earnings per share of $0.09 excluding restructuring charges.

Nu Skin Enterprises' Q4 2023 revenue was $488.6 million, a decrease of 6% year-over-year, while Rhyz revenue increased by 101% to $65.1 million. EPS was $0.15, or $0.37 excluding restructuring and other charges.

Nu Skin Enterprises reported Q3 2023 revenue of $498.8 million, a decrease compared to $537.8 million in the prior-year quarter. The company experienced a loss per share (EPS) of $(0.74), or $0.56 excluding an inventory write-off, compared to $(0.51) or $0.47 excluding restructuring and impairment charges in the prior year. The company is strategically re-evaluating several aspects of its Nu Skin business, including product portfolio, global processes and organization, and operational footprint and aggressively managing costs to help drive growth and profitability.

Nu Skin Enterprises reported second quarter 2023 results in line with expectations, driven by gains in Mainland China and Rhyz segments, while being impacted by macro-economic factors in key markets.

Nu Skin Enterprises reported first quarter 2023 financial results that were in line with expectations. Revenue was $481.5 million, a decrease of 20% compared to the prior-year quarter. EPS was $0.23, or $0.37 excluding restructuring and impairment charges, compared to $0.76 in the prior-year quarter. The company reiterated its 2023 guidance, expecting gradual sequential improvements throughout the year.

Nu Skin Enterprises reported Q4 2022 results with a decrease in revenue to $522.3 million and EPS of $1.15, or $0.89 excluding certain charges. The company is progressing with its Nu Vision 2025 strategy, focusing on personalized beauty and wellness.

Nu Skin Enterprises reported a decrease in revenue and a net loss per share due to worsening macro headwinds, including COVID-related disruptions in Mainland China, a slowdown in South Korea, global inflation, and foreign currency pressure. However, the company saw constant-currency growth in Southeast Asia/Pacific, the U.S., Japan and Taiwan/Hong Kong segments.

Nu Skin Enterprises reported a decrease in revenue and earnings per share for the second quarter of 2022, impacted by COVID-19, geopolitical issues, and economic conditions. The company is focusing on Nu Vision 2025 and implementing restructuring measures to reduce operating expenses.

Nu Skin Enterprises reported first-quarter revenue of $604.9 million and EPS of $0.76, outperforming guidance despite global uncertainties and COVID-related obstacles. Demand for new products like ageLOC® Meta and Beauty Focus™ Collagen+ drove growth in several markets, while Mainland China and EMEA were negatively impacted by COVID-related lockdowns and geopolitical conflict.

Nu Skin Enterprises reported a Q4 revenue of $673.4 million, a 10% decrease compared to the prior-year quarter. EPS was reported at $(0.18), or $1.11 excluding restructuring and impairment charges. The company is focusing on its Nu Vision 2025 strategy to accelerate growth.

Nu Skin Enterprises reported a decrease in revenue and EPS for Q3 2021 compared to the prior-year quarter, primarily due to COVID-19 related disruptions in Mainland China and Southeast Asia. However, growth in the U.S. and Korea provided some offset. The company is adjusting its 2021 forecast due to continued COVID uncertainty.

Nu Skin Enterprises reported a strong second quarter with a 15% increase in revenue to $704.1 million and a 42% increase in EPS to $1.15, driven by growth in beauty device systems, adoption of social commerce and improved operating margin.

Nu Skin Enterprises reported record first-quarter 2021 results with a 31% increase in revenue and a 153% increase in EPS. The company's growth was fueled by innovative beauty and wellness product initiatives and a social commerce business model, leading to a 34% growth in the customer base and a 22% increase in global sales leaders. The company also raised its annual guidance.

Nu Skin Enterprises reported a 28% increase in revenue and a 94% increase in EPS for Q4 2020. The company's performance was driven by strong customer growth and successful product launches, particularly in the West markets. The company is projecting continued revenue and EPS growth in 2021.

Nu Skin Enterprises reported a strong third quarter with a 19% increase in revenue and a 37% increase in earnings per share. The company's performance was driven by strong product demand and ongoing digital investments, with growth in customers and sales leaders.

Nu Skin Enterprises reported second-quarter results above expectations and raised its revenue and earnings per share guidance for 2020. Strong global customer growth of 29 percent in the quarter, driven by focus on empowering sales leaders to reach more customers, resulted in constant currency revenue growth due to the strength of business in the Americas and Europe.

Nu Skin Enterprises reported Q1 2020 revenue and earnings above guidance, driven by the efforts of sales leaders and global teams, despite challenges posed by COVID-19. The company saw continued stability with strong customer activity, supported by digital properties and effective supply chain management.

Nu Skin Enterprises reported Q4 2019 revenue of $583.4 million and EPS of $0.72. The company's sales leader count decreased, primarily driven by a decline in Mainland China, while manufacturing entities experienced growth. The company provided 2020 guidance, anticipating the coronavirus outbreak to significantly impact the business in the near term.